Research & Development
Pipeline
A paradigm shift in antibody discovery for cancer
We have developed an advanced, innovative and efficient high-throughput single B cell culturing platform to rapidly discover and generate completely human-derived, tumor-targeted recombinant antibodies for the treatment of a variety of cancers.